Mitigating cost increases through preemptive care and clinical efficacy to reduce the disease burden of clinically at-risk patients.
Lonny Reisman, MD, Chief Executive Officer, HealthReveal
Advertisement
Articles by Lonny Reisman, MD, Chief Executive Officer, HealthReveal
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
How Often Do Health Insurers Deny Doctor-Recommended Care?
2
Acoramidis Shows Durable Benefit at 54 Months in ATTR-CM
3
Sudden Death in HFpEF Often Preceded by Clinical Decline
4
New Data Support Pimicotinib as Durable for Rare Tenosynovial Giant Cell Tumor
5